ANEBULO PHARMACEUTICALS, INC. Payments of Financing Costs
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Payments of Financing Costs of $116.66 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2025-09-29
- ANEBULO PHARMACEUTICALS, INC. payments of financing costs for the quarter ending 2025-06-30 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. payments of financing costs for the quarter ending 2024-06-30 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. payments of financing costs for the quarter ending 2024-03-31 was $0.00.
- ANEBULO PHARMACEUTICALS, INC. payments of financing costs for fiscal 2025 was $116.66K, a 87.10% increase from fiscal 2024.
- ANEBULO PHARMACEUTICALS, INC. payments of financing costs for fiscal 2024 was $62.35K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $116.66K 10-K · filed 2025-09-29 | ||
| 2025-03-31 | $116.66K 10-Q · filed 2025-05-13 | |||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2025-09-29 | $62.35K 10-K · filed 2025-09-29 | |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $62.35K 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | $62.35K 10-Q · filed 2025-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |